NEU neuren pharmaceuticals limited

Ann: Validation for NNZ-2591 neurodevelopmental disorder pipeline, page-75

  1. 1,256 Posts.
    lightbulb Created with Sketch. 311
    It doesn’t make a lot of sense to do all the heavy lifting with trof and then not want ROW. 2591 may qualify for BT which would fast track development, if I was Acadia I would want 2591as well. Bring in Torreya and btw the first rule when negotiating is being prepared to walk away.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.07
Change
0.220(1.71%)
Mkt cap ! $1.626B
Open High Low Value Volume
$13.15 $13.37 $12.92 $5.668M 432.2K

Buyers (Bids)

No. Vol. Price($)
19 728 $13.07
 

Sellers (Offers)

Price($) Vol. No.
$13.08 327 6
View Market Depth
Last trade - 14.46pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.